Prognostic and predictive value of HER2/neu oncogene in breast cancer. - Wikidata - awgldk - TriplyDB

Prognostic and predictive value of HER2/neu oncogene in breast cancer.

Prognostic and predictive value of HER2/neu oncogene in breast cancer.

http://www.wikidata.org/entity/Q34954864

about

Phyto-oestrogens and breast cancer chemoprevention c-myc, not her-2/neu, can predict the prognosis of breast cancer patients: how novel, how accurate, and how significant?HER2 testing: a review of detection methodologies and their clinical performance Investigation and molecular mimicry of the antigen involved in the interaction between the monoclonal antibody 5D10 and the human breast cancer cell line MCF-7.Using image analysis as a tool for assessment of prognostic and predictive biomarkers for breast cancer: How reliable is it?Development of an integrated genomic classifier for a novel agent in colorectal cancer: approach to individualized therapy in early development.Biologic and therapeutic role of HER2 in cancer.Clinical implications of advanced molecular cytogenetics in cancer.Targeted therapy in breast cancer: the HER-2/neu gene and protein.Adjuvant trastuzumab: progress, controversies, and the steps ahead.Digital karyotyping technology: exploring the cancer genome.Studying copy number variations using a nanofluidic platform.Applying genomics to organ transplantation medicine in both discovery and validation of biomarkers.Multiple protein analysis of formalin-fixed and paraffin-embedded tissue samples with reverse phase protein arrays Genetic tests and genomic biomarkers: regulation, qualification and validation HER2 as a target for breast cancer therapy.Biomarkers: refining diagnosis and expediting drug development - reality, aspiration and the role of open innovation.Significance of HER2 and C-MYC oncogene amplifications in breast cancer in atomic bomb survivors: associations with radiation exposure and histologic grade.Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?The molecular analysis of breast cancer utilizing targeted nanoparticle based ultrasound contrast agents.

P2860

Q24794947-554A3E76-CB25-4890-9CC5-30E30FE8FE9F Q24803848-4FA57920-7A66-4904-A675-FEFFB4A1AD6C Q28280488-C5C90A41-A7C0-4C70-B493-B279E61D0F8C Q33266159-D1B4FF8B-A99E-452B-81DD-4B4EA6B9EF64 Q33789913-D5E72F75-B221-4B92-BA66-E683AF8CA29F Q33927952-1E5E9BDA-DED6-4D26-AC50-5E0CF123D2B2 Q34267775-F6FFCAE0-43F9-496E-B95E-0E23B42405C5 Q35623360-086A403D-80D5-4CCC-8CAB-068623AE4A02 Q35648508-49833993-FC2D-4E13-812E-C47B8C2CCA10 Q35840342-A9F4CF35-F97B-41C8-8F72-29EA8DAF2B44 Q36299912-0732D8B2-6577-467C-8E06-9BFB9C2797BC Q36935421-3DE7F061-36C1-49C2-B9A4-68446A15859C Q37015023-2DE39157-3981-45F2-8CDB-D106D73D9C6F Q37160952-E129E8B1-71D9-43EE-95A1-FBD552B1F5DA Q37430324-544F39DA-A0D1-4103-8004-4E7579729698 Q37705396-B1FF8AEB-E3CB-4AD6-9CA6-AD2074A769DA Q38194173-61AC4755-2161-42B0-B940-CD982D477E2C Q46695515-E69EB86D-C86A-4A09-8ECD-B80AA091547F Q47164059-D1C2E656-4A03-414F-8E31-DF99B62F26BD Q51319155-53C6CFDE-20CF-4762-AF88-FCD4A859FBDF

P2860

Prognostic and predictive value of HER2/neu oncogene in breast cancer.

http://www.wikidata.org/entity/Q34954864

description

2002 nî lūn-bûn

@nan

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Prognostic and predictive value of HER2/neu oncogene in breast cancer.

@ast

Prognostic and predictive value of HER2/neu oncogene in breast cancer.

@en

Prognostic and predictive value of HER2/neu oncogene in breast cancer.

@nl

type

label

Prognostic and predictive value of HER2/neu oncogene in breast cancer.

@ast

Prognostic and predictive value of HER2/neu oncogene in breast cancer.

@en

Prognostic and predictive value of HER2/neu oncogene in breast cancer.

@nl

prefLabel

Prognostic and predictive value of HER2/neu oncogene in breast cancer.

@ast

Prognostic and predictive value of HER2/neu oncogene in breast cancer.

@en

Prognostic and predictive value of HER2/neu oncogene in breast cancer.

@nl

P1433

Q34954864-81ACB4A7-C734-4AD7-866A-BD6BC0312435

P1476

Q34954864-F7AF0ABE-17B7-44C0-828C-7982073F153E

P2093

Q34954864-4E326EEE-66F9-4149-8BB2-A897DB6E749D

Q34954864-89EDC25E-44DD-4408-AED2-98FBDA7DC4FF

P2860

Q34954864-1A4E38AE-584C-42AB-B3D2-5C237049E7B5

Q34954864-2043D9FE-5A3F-49BD-87C7-DC4EE1BA4097

Q34954864-236C5B9B-8B25-48FB-A98D-066AFAD04544

Q34954864-26FCB8D6-23DE-4E37-8303-99DB8492FA92

Q34954864-30787128-2993-4A2A-A17D-C1AC49FCEE93

Q34954864-31DA8578-FD54-43B2-991B-4D849344061A

Q34954864-3C6A9706-802F-4DC5-B581-D3CD8352B241

Q34954864-3E46E3E0-D1C8-4525-9B58-2D133C37E550

Q34954864-4A69BB6B-61D4-4B53-88DE-B96849F6C9D2

Q34954864-5238FBED-7475-4F9C-9443-FB833D9C1B95

P304

Q34954864-D6F0F2E5-8887-4007-A28B-1B4FC82154B6

P31

Q34954864-39C03F0B-4686-4E13-B9B7-5832CC3716C7

P356

Q34954864-545FC584-B17A-48D1-9D57-67BC0C7AABD9

P433

Q34954864-2B5550EC-D711-463D-8462-CB801387C1C7

P478

Q34954864-C7466DBA-C6DD-41B0-8E36-CD34CE86C134

P577

Q34954864-13603D6B-D52B-418A-91A4-CA63D36EA48E

P698

Q34954864-F48E532F-D442-4EE3-9488-7B9FF7F70A35

P356

P1433

Microscopy Research and Technique

P1476

Prognostic and predictive value of HER2/neu oncogene in breast cancer.

@en

P2093

Marilyn M Bui

http://www.w3.org/2001/XMLSchema#string

Shahla Masood

http://www.w3.org/2001/XMLSchema#string

P2860

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.

Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors.

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.

c-erbB-2 oncoprotein expression in primary and advanced breast cancer

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.

P304

102-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JEMT.10181

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12373720

http://www.w3.org/2001/XMLSchema#string